Skip to main content
Skip to primary sidebar

Biotech Briefings

Home
About
Editors
Topics
Subscribe

Home
About
Editors
Topics
Subscribe

MailPoet Page

December 18, 2024 | Posted by

[mailpoet_page]

Primary Sidebar

Search this website

Gibson Dunn Life Sciences
2025 Outlook Webcast Series

Capital Markets: Click here to view the video recording and program materials.

Royalty Finance: Click here to view the video recording and program materials.

Read ROYALTY REPORT here.

Topics

Capital Markets

Clinical Trials

False Claims Act

Government Regulation

International Trade

Reverse Mergers

Royalty Finance

Securities Litigation

Shareholder Activism

Trends and Insights

Editors

Branden C. Berns

Lindsay Bernsen Wardlaw

Aaron K. Briggs

Gustav W. Eyler

Carlo Felizardo

Charlotte Jacobsen

Jane M. Love, Ph.D.

Mary Beth Maloney

Katlin McKelvie

Melanie E. Neary

John D.W. Partridge

Jonathan Phillips

Lindsey D. Schmidt

Samantha Sewall

Karen A. Spindler

Todd J. Trattner

Stephen Weissman

Useful Links

Gibson Dunn Website
Gibson Dunn Life Sciences Landing page
Securities Regulation and Corporate Governance Monitor
NVCA Model Legal Documents
Royalty Finance Tracker
Royalty Report: Royalty Finance Transactions in the Life Sciences 2020-2024
IPO Resource Center
IP Disputes and Litigation

Archives

Archives

Subscribe to Updates

Privacy Statement
Cookie Notice
Contact Us

© 2025 Gibson, Dunn & Crutcher LLP. All rights reserved.